Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul 14:6:685.
doi: 10.3389/fmicb.2015.00685. eCollection 2015.

Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases

Affiliations
Review

Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases

Natallia V Varankovich et al. Front Microbiol. .

Abstract

Probiotic bacteria offer a number of potential health benefits when administered in sufficient amounts that in part include reducing the number of harmful organisms in the intestine, producing antimicrobial substances and stimulating the body's immune response. However, precisely elucidating the probiotic effect of a specific bacterium has been challenging due to the complexity of the gut's microbial ecosystem and a lack of definitive means for its characterization. This review provides an overview of widely used and recently described probiotics, their impact on the human's gut microflora as a preventative treatment of disease, human/animal models being used to help show efficacy, and discusses the potential use of probiotics in gastrointestinal diseases associated with antibiotic administration.

Keywords: antibiotic resistance; gastrointestinal disorders; gut microbiota; human gut; probiotic.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Aiba Y., Suzuki N., Kabir A. M., Takagi A., Koga Y. (1998). Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am. J. Gastroenterol. 93 2097–2101. 10.1111/j.1572-0241.1998.00600.x - DOI - PubMed
    1. AlFaleh K., Anabrees J. (2014). Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. 2014:CD005496 10.1002/14651858.CD005496.pub4 - DOI - PubMed
    1. Andoh A., Kuzuoka H., Tsujikawa T., Nakamura S., Hirai F., Suzuki Y., et al. (2012). Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease. J. Gastroenterol. 47 1298–1307. 10.1007/s00535-012-0605-0 - DOI - PubMed
    1. Armuzzi A., Cremonini F., Bartolozzi F., Canducci F., Candelli M., Ojetti V., et al. (2001). The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment. Pharmacol. Ther. 15 163–169. 10.1046/j.1365-2036.2001.00923.x - DOI - PubMed
    1. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D. R., et al. (2013). Enterotypes of the human gut microbiome. Nature 473 174–180. 10.1038/nature09944 - DOI - PMC - PubMed

LinkOut - more resources